NeoGenomics (NEO) News Today $7.10 +0.09 (+1.30%) As of 10:19 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NEO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period NeoGenomics Expands Board, Appoints New DirectorJune 24 at 7:29 AM | tipranks.comNeoGenomics Appoints Dr. Marjorie Green to Board of DirectorsJune 24 at 7:05 AM | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEOJune 23 at 12:24 PM | globenewswire.comAdvisor Resource Council Makes New $872,000 Investment in NeoGenomics, Inc. (NASDAQ:NEO)Advisor Resource Council bought a new position in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The fund bought 96,343 shares of the medical research company's stock, valued at approximately $872,000. AdvisorJune 22 at 4:23 AM | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) Given Average Rating of "Hold" by AnalystsShares of NeoGenomics, Inc. (NASDAQ:NEO - Get Free Report) have been given a consensus recommendation of "Hold" by the eleven research firms that are presently covering the company, MarketBeat.com reports. Six research analysts have rated the stock with a hold recommendation and five have issued aJune 18, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEOJune 17, 2025 | prnewswire.comNeoGenomics (NASDAQ:NEO) Sees Strong Trading Volume - Here's What HappenedNeoGenomics (NASDAQ:NEO) Sees Strong Trading Volume - What's Next?June 16, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEOJune 15, 2025 | globenewswire.comNeoGenomics (NASDAQ:NEO) Stock Price Down 5.2% - Here's WhyNeoGenomics (NASDAQ:NEO) Trading Down 5.2% - Here's What HappenedJune 12, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEOJune 12, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEOJune 7, 2025 | prnewswire.comNeoGenomics, Inc. (NASDAQ:NEO) Short Interest Up 32.2% in MayNeoGenomics, Inc. (NASDAQ:NEO - Get Free Report) was the recipient of a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 6,280,000 shares, an increase of 32.2% from the April 30th total of 4,750,000 shares. Approximately 5.0% of the shares of the stock are sold short. Based on an average trading volume of 2,070,000 shares, the short-interest ratio is currently 3.0 days.June 3, 2025 | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 7.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 646,111June 1, 2025 | marketbeat.comNuveen Asset Management LLC Sells 98,179 Shares of NeoGenomics, Inc. (NASDAQ:NEO)Nuveen Asset Management LLC lessened its stake in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 22.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 345,667 shares of the medical researJune 1, 2025 | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) Director Michael Aaron Kelly Purchases 5,000 SharesNeoGenomics, Inc. (NASDAQ:NEO - Get Free Report) Director Michael Aaron Kelly acquired 5,000 shares of the firm's stock in a transaction dated Tuesday, May 27th. The stock was bought at an average price of $7.60 per share, with a total value of $38,000.00. Following the purchase, the director now directly owns 5,000 shares in the company, valued at approximately $38,000. This trade represents a ∞ increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.May 30, 2025 | marketbeat.comNeoGenomics unveils new oncology diagnostics at ASCO 2025May 29, 2025 | investing.comNeoGenomics, Inc. (NASDAQ:NEO) Director Buys $38,000.00 in StockMay 29, 2025 | insidertrades.comNeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025May 29, 2025 | finance.yahoo.comBNP Paribas Financial Markets Sells 35,979 Shares of NeoGenomics, Inc. (NASDAQ:NEO)BNP Paribas Financial Markets trimmed its holdings in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 49.3% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 36,984 shares of the medical research company's stock after selling 35,979 shares durinMay 26, 2025 | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) Receives Average Rating of "Hold" from AnalystsNeoGenomics, Inc. (NASDAQ:NEO - Get Free Report) has been given an average rating of "Hold" by the eleven ratings firms that are presently covering the firm, MarketBeat reports. Six investment analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on thMay 26, 2025 | marketbeat.comNeoGenomics introduces c-MET companion diagnostic for NSCLCMay 23, 2025 | finance.yahoo.comNeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung CancerMay 22, 2025 | businesswire.comNeoGenomics to Participate in Upcoming June Investor ConferencesMay 20, 2025 | businesswire.comGraham Capital Management L.P. Acquires 51,626 Shares of NeoGenomics, Inc. (NASDAQ:NEO)Graham Capital Management L.P. raised its holdings in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 467.5% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 62,669 shares of the medical research company's stock after buyiMay 16, 2025 | marketbeat.comJanus Henderson Group PLC Has $101.60 Million Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO)Janus Henderson Group PLC lessened its holdings in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 6.6% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 6,165,063 shares of the medical research company's stock after selling 438,117 shares during theMay 15, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Sells 54,330 Shares of NeoGenomics, Inc. (NASDAQ:NEO)Schonfeld Strategic Advisors LLC lowered its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 76.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 16,280 shares of the medical research comMay 15, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Upgraded to Hold at StockNews.comStockNews.com upgraded shares of NeoGenomics from a "sell" rating to a "hold" rating in a report on Tuesday.May 15, 2025 | marketbeat.comInsider Buying: NeoGenomics, Inc. (NASDAQ:NEO) COO Acquires 5,700 Shares of StockMay 14, 2025 | insidertrades.comNEO Q1 Earnings Call: Sales Growth, Pharma Headwinds, and Pathline Integration Shape OutlookMay 13, 2025 | finance.yahoo.comNorthern Trust Corp Boosts Stock Position in NeoGenomics, Inc. (NASDAQ:NEO)Northern Trust Corp grew its holdings in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 7.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,621,809 shares of the medical research company's stockMay 13, 2025 | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) Shares Sold by Price T Rowe Associates Inc. MDPrice T Rowe Associates Inc. MD lowered its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 78.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 91,574 shares of the medical research company's stock aftMay 11, 2025 | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) Position Lowered by Fred Alger Management LLCFred Alger Management LLC reduced its position in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 3.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,712,959 shares of the medical research company's stoMay 10, 2025 | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) Director Acquires $31,120.00 in StockMay 10, 2025 | insidertrades.comChief Financial Officer of NeoGenomics Jeffrey Sherman Buys 14% More SharesMay 9, 2025 | finance.yahoo.comNeoGenomics, Inc. (NASDAQ:NEO) CEO Buys $148,932.00 in StockMay 9, 2025 | insidertrades.comVoya Investment Management LLC Has $1.02 Million Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO)Voya Investment Management LLC decreased its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 98.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 61,688 shares of theMay 9, 2025 | marketbeat.comA Look at NeoGenomics's Upcoming Earnings ReportMay 8, 2025 | benzinga.comNeoGenomics, Inc. (NASDAQ:NEO) Director Buys 10,000 SharesMay 8, 2025 | insidertrades.comTudor Investment Corp ET AL Cuts Holdings in NeoGenomics, Inc. (NASDAQ:NEO)Tudor Investment Corp ET AL lessened its position in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 59.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 87,353 shares of the medical research cMay 8, 2025 | marketbeat.comFirst Trust Advisors LP Raises Holdings in NeoGenomics, Inc. (NASDAQ:NEO)First Trust Advisors LP lifted its holdings in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 316.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 132,180 shares of the medical research company's stock after purchMay 8, 2025 | marketbeat.comRaymond James Financial Inc. Takes $839,000 Position in NeoGenomics, Inc. (NASDAQ:NEO)Raymond James Financial Inc. purchased a new position in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 50,906 shares of the medical researMay 8, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Trading 5.3% Higher - Here's What HappenedNeoGenomics (NASDAQ:NEO) Shares Up 5.3% - Time to Buy?May 7, 2025 | marketbeat.comNeoGenomics First Quarter 2025 Earnings: EPS Beats Expectations, Revenues LagMay 7, 2025 | finance.yahoo.comNeoGenomics, Inc. (NASDAQ:NEO) Shares Sold by Brown Advisory Inc.Brown Advisory Inc. cut its position in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 10.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,156,061 shares of the medical research company's stock after sellinMay 7, 2025 | marketbeat.comInsider Buying: NeoGenomics, Inc. (NASDAQ:NEO) CFO Purchases 20,000 Shares of StockMay 7, 2025 | insidertrades.com3NEO : Assessing NeoGenomics: Insights From 9 Financial AnalystsMay 7, 2025 | benzinga.comIt's Not Too Late to Jump on These Under-the-Radar Momentum Plays (NEO)These three stocks may fly under the radar, but their recent price increases could appeal to investors seeking a momentum play.May 6, 2025 | marketbeat.comBellevue Group AG Sells 556,816 Shares of NeoGenomics, Inc. (NASDAQ:NEO)Bellevue Group AG lowered its holdings in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 34.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,055,796 shares of the medical research company's stoMay 6, 2025 | marketbeat.comDimensional Fund Advisors LP Buys 78,211 Shares of NeoGenomics, Inc. (NASDAQ:NEO)Dimensional Fund Advisors LP raised its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 2.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 3,436,858 shares of the medical research company's stock after purchasing an additiMay 5, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Downgraded by Leerink Partnrs to "Hold"Leerink Partnrs cut NeoGenomics from a "strong-buy" rating to a "hold" rating in a report on Wednesday.May 3, 2025 | marketbeat.com Get NeoGenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Videos NEO Media Mentions By Week NEO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NEO News Sentiment▼0.540.62▲Average Medical News Sentiment NEO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NEO Articles This Week▼55▲NEO Articles Average Week Get NeoGenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TriNet Group News Concentrix News CarGurus News Autohome News First Advantage News PagSeguro Digital News DLocal News Clarivate News DXC Technology News Hinge Health News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NEO) was last updated on 6/24/2025 by MarketBeat.com Staff From Our PartnersSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | Sponsored12 “perfect” stocksJoin the Dream Team and see how we can guarantee stock market wins Credentials are a good thing, especiall...Zacks | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredYour portfolio has a dangerous blind spot (fix it now)The next overnight crash could happen any day. Will you be protected or exposed? Register now to learn how som...Ninjacators | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeoGenomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeoGenomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
